Ubs Asset Management Americas Inc Ionis Pharmaceuticals Inc Transaction History
Ubs Asset Management Americas Inc
- $417 Billion
- Q4 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 619,641 shares of IONS stock, worth $20.3 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
619,641
Previous 285,697
116.89%
Holding current value
$20.3 Million
Previous $11.4 Million
89.27%
% of portfolio
0.01%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding IONS
# of Institutions
412Shares Held
140MCall Options Held
829KPut Options Held
789K-
Vanguard Group Inc Valley Forge, PA16.5MShares$538 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$463 Million0.31% of portfolio
-
Capital World Investors Los Angeles, CA11.5MShares$375 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$337 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.67MShares$283 Million0.06% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.64B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...